176 related articles for article (PubMed ID: 29073807)
1. An Assessment of a Shortened Consent Form for the Storage and Research Use of Residual Newborn Screening Blood Spots.
Rothwell E; Goldenberg A; Johnson E; Riches N; Tarini B; Botkin JR
J Empir Res Hum Res Ethics; 2017 Dec; 12(5):335-342. PubMed ID: 29073807
[TBL] [Abstract][Full Text] [Related]
2. The Influence of Education on Public Trust and Consent Preferences With Residual Newborn Screening Dried Blood spots.
Rothwell E; Wong B; Anderson RA; Botkin JR
J Empir Res Hum Res Ethics; 2016 Jul; 11(3):231-6. PubMed ID: 27387457
[TBL] [Abstract][Full Text] [Related]
3. The view of Hong Kong parents on secondary use of dried blood spots in newborn screening program.
Hui LL; Nelson EAS; Deng HB; Leung TY; Ho CH; Chong JSC; Fung GPG; Hui J; Lam HS
BMC Med Ethics; 2022 Nov; 23(1):105. PubMed ID: 36319979
[TBL] [Abstract][Full Text] [Related]
4. The use of newborn screening dried blood spots for research: the parental perspective.
Gong LM; Tu WJ; He J; Shi XD; Wang XY; Li Y
J Bioeth Inq; 2012 Jun; 9(2):189-93. PubMed ID: 23180262
[TBL] [Abstract][Full Text] [Related]
5. Michigan BioTrust for Health: public support for using residual dried blood spot samples for health research.
Duquette D; Langbo C; Bach J; Kleyn M
Public Health Genomics; 2012; 15(3-4):146-55. PubMed ID: 22488457
[TBL] [Abstract][Full Text] [Related]
6. A comparative analysis of the governance and use of residual dried blood spots from state newborn screening programs and neonatal biobanks.
Preslan ED; Mathews DJ
J Empir Res Hum Res Ethics; 2013 Jul; 8(3):22-33. PubMed ID: 23933773
[TBL] [Abstract][Full Text] [Related]
7. Attitudes about the use of newborn dried blood spots for research: a survey of underrepresented parents.
Hendrix KS; Meslin EM; Carroll AE; Downs SM
Acad Pediatr; 2013; 13(5):451-7. PubMed ID: 24011748
[TBL] [Abstract][Full Text] [Related]
8. Common criteria among States for storage and use of dried blood spot specimens after newborn screening.
Petrini C; Olivieri A; Corbetta C; Cerone R; D'Agnolo G; Bompiani A
Ann Ist Super Sanita; 2012; 48(2):119-21. PubMed ID: 22751553
[TBL] [Abstract][Full Text] [Related]
9. IRB review and public health biobanking: a case study of the Michigan BioTrust for Health.
Mongoven A; McGee H
IRB; 2012; 34(3):11-6. PubMed ID: 22830178
[No Abstract] [Full Text] [Related]
10. From newborn screening to population health research: implementation of the Michigan BioTrust for health.
Langbo C; Bach J; Kleyn M; Downes FP
Public Health Rep; 2013; 128(5):377-84. PubMed ID: 23997284
[TBL] [Abstract][Full Text] [Related]
11. Parental perspectives on retention and secondary use of neonatal dried bloodspots: a Dutch mixed methods study.
Jansen ME; van den Bosch LJM; Hendriks MJ; Scheffer MMJ; Heijnen ML; Douglas CMW; van El CG
BMC Pediatr; 2019 Jul; 19(1):230. PubMed ID: 31288776
[TBL] [Abstract][Full Text] [Related]
12. Not without my permission: parents' willingness to permit use of newborn screening samples for research.
Tarini BA; Goldenberg A; Singer D; Clark SJ; Butchart A; Davis MM
Public Health Genomics; 2010; 13(3):125-30. PubMed ID: 19602864
[TBL] [Abstract][Full Text] [Related]
13. Residual newborn screening samples for research: parental information needs for decision-making.
Rothwell E; Clark L; Anderson R; Botkin JR
J Spec Pediatr Nurs; 2013 Apr; 18(2):115-22. PubMed ID: 23560583
[TBL] [Abstract][Full Text] [Related]
14. Biobanking in Israel 2016-17; expressed perceptions versus real life enrollment.
Koren G; Beller D; Laifenfeld D; Grossman I; Shalev V
BMC Med Ethics; 2017 Nov; 18(1):63. PubMed ID: 29149849
[TBL] [Abstract][Full Text] [Related]
15. Research use of leftover newborn bloodspots: attitudes of Canadian geneticists regarding storage and informed consent requirements.
Richer J; Ghebremichael MS; Chudley AE; Robinson WM; Wilfond BS; Solomon MZ
Genet Med; 2011 Apr; 13(4):305-13. PubMed ID: 20921895
[TBL] [Abstract][Full Text] [Related]
16. Using Newborn Screening Bloodspots for Research: Public Preferences for Policy Options.
Hayeems RZ; Miller FA; Barg CJ; Bombard Y; Cressman C; Painter-Main M; Wilson B; Little J; Allanson J; Avard D; Giguere Y; Chakraborty P; Carroll JC
Pediatrics; 2016 Jun; 137(6):. PubMed ID: 27244855
[TBL] [Abstract][Full Text] [Related]
17. Implementation of informed consent for a cystic fibrosis newborn screening program in France: low refusal rates for optional testing.
Dhondt JL
J Pediatr; 2005 Sep; 147(3 Suppl):S106-8. PubMed ID: 16202772
[TBL] [Abstract][Full Text] [Related]
18. A survey to evaluate parental consent as public policy for neonatal screening.
Faden R; Chwalow AJ; Holtzman NA; Horn SD
Am J Public Health; 1982 Dec; 72(12):1347-52. PubMed ID: 7137431
[TBL] [Abstract][Full Text] [Related]
19. Assessment of a shortened informed consent form for pediatric research: a pilot study.
Murray PD; Bierer BE; Hirschfeld S; Klein AK; Davis JM
Pediatr Res; 2018 Oct; 84(4):516-519. PubMed ID: 29967521
[TBL] [Abstract][Full Text] [Related]
20. Standard Versus Simplified Consent Materials for Biobank Participation: Differences in Patient Knowledge and Trial Accrual.
Garrett SB; Murphy M; Wiley J; Dohan D
J Empir Res Hum Res Ethics; 2017 Dec; 12(5):326-334. PubMed ID: 29037106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
